Compound ID | 989
Class: Gramicidin
Details of activity: | Unlike actinomycin, would not seem to bind/inhibit DNA/RNA polymerase. Anti-tumour antibiotic. |
Institute where first reported: | Chester Beatty Research institute, Institute of cancer research, Royal Cancer Hospital |
Year first mentioned: | 1966 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
External links: | |
Citations: |
|